Tiger Brokers

BUZZ-Capricor jumps to 8-year high as cell therapy slows muscle-wasting disease

Reuters
Dec 03, 2025
BUZZ-Capricor jumps to 8-year high as cell therapy slows muscle-wasting disease

** Shares of drugmaker Capricor Therapeutics CAPR.O surge fourfold to $29.72, its highest in over 8 years

** Co says its experimental cell therapy, deramiocel, slowed the progression of Duchenne muscular dystrophy or DMD in a late-stage trial

** DMD is a condition that causes skeletal and heart muscle weakness that quickly gets worse with time

** Co says deramiocel slowed DMD progression by 54% vs placebo

** Disease causes muscle weakness and heart problems; affects about 15,000 people in U.S. - CAPR

** Co has exclusive deal with Japan's Nippon Shinyaku to sell deramiocel in U.S. and Japan, if approved

** Including session's move, stock up ~175% YTD

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10